- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 307/24 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Patent holdings for IPC class C07D 307/24
Total number of patents in this class: 121
10-year publication summary
|
13
|
10
|
11
|
8
|
7
|
9
|
12
|
12
|
9
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Corsair Pharma, Inc. | 36 |
9 |
| Vertex Pharmaceuticals Incorporated | 1570 |
6 |
| BASF SE | 20367 |
5 |
| BioTheryX, Inc. | 100 |
5 |
| Eastman Chemical Company | 2252 |
4 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 803 |
4 |
| 3m Innovative Properties Company | 17968 |
3 |
| Boehringer Ingelheim International GmbH | 4762 |
3 |
| Archer Daniels Midland Company | 1138 |
3 |
| Modernatx, Inc. | 1209 |
3 |
| Novartis AG | 11297 |
2 |
| AstraZeneca AB | 2961 |
2 |
| Bayer AG | 3202 |
2 |
| Bayer Cropscience AG | 2143 |
2 |
| Bioprojet | 49 |
2 |
| Mitsubishi Tanabe Pharma Corporation | 575 |
2 |
| Rennovia, Inc. | 21 |
2 |
| Rhodia Operations | 1588 |
2 |
| Symrise AG | 1666 |
2 |
| Zhejiang Ausun Pharmaceutical Co., Ltd. | 35 |
2 |
| Other owners | 56 |